News & Perspective

Oct 28, 2010

Oct 28, 2010

CDC sees smooth road so far for flu vaccine

(CIDRAP News) – In a flu vaccine update at a federal advisory meeting today, officials with the US Centers for Disease Control and Prevention (CDC) said early signs suggest flu vaccine uptake in children is on par with last year and that enhanced monitoring for narcolepsy and seizures has turned up no signals of trouble.

May 21, 2010

May 21, 2010

WHO: Pandemic showed limits of vaccine production capacity

(CIDRAP News) – Global production of the H1N1 influenza vaccine has made clear that the world still has a long way to go to meet pandemic production capacity goals set by the World Health Organization (WHO) 4 years ago, WHO experts said in a report released this week.

Apr 06, 2010

Apr 06, 2010

Analysis finds Ontario's universal flu vaccination policy cost-effective

(CIDRAP News) – An analysis of Ontario's universal flu vaccination program, which targets free flu vaccine for anyone over 6 months old, is cost-effective and may be an attractive option for other provinces and countries that have single-payer health systems, researchers reported today.

Apr 06, 2010

New Canadian studies suggest seasonal flu shot increased H1N1 risk

(CIDRAP News) – Despite a rapidly launched range of studies, investigators in Canada are still unable to say—or to rule out—whether receiving a seasonal flu vaccination in the 2008-09 season made it more likely that Canadians would become ill from 2009 pandemic H1N1 flu.

Sep 24, 2009

Sep 24, 2009

Unpublished Canadian data on seasonal flu shots and H1N1 stir concern

(CIDRAP News) – Canadian researchers reportedly have found as-yet-unpublished evidence that people who had a seasonal flu shot last year incurred a higher risk of H1N1 infection, but US and World Health Organization (WHO) officials say they are not aware of any similar findings elsewhere.

Sep 18, 2009

Sep 18, 2009

CDC says 3.4 million doses of H1N1 vaccine to ship in early October

(CIDRAP News) – The first wave of H1N1 vaccine will probably consist of 3.4 million doses of MedImmune's nasal-spray product and is likely to reach providers the first week in October, federal health officials said today.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»